General pathogenic bacteria

General pathogenic bacteria refers to a broad category of prokaryotic microorganisms that cause infectious diseases in human hosts through mechanisms such as toxin production, tissue invasion, and immune evasion (StatPearls, NBK544290). This classification is not a single molecular target but rather a group of organisms that contain numerous specific therapeutic targets, including the bacterial cell wall, ribosomes, and DNA-modulating enzymes (NIH, PMC4378521). Drugs that interact with these pathogens, known as antibiotics, are designed to exploit the biological differences between bacteria and humans to achieve selective toxicity. Common mechanisms of action include the inhibition of peptidoglycan synthesis, interference with the 30S or 50S ribosomal subunits, and the inhibition of topoisomerases. The primary challenge in targeting these organisms is the global rise of antimicrobial resistance, which renders many traditional treatments ineffective (WHO, Antimicrobial resistance). Additionally, broad-spectrum antibiotics can lead to the disruption of the host's commensal microbiome, potentially resulting in secondary infections like Clostridioides difficile. Effective management of bacterial infections often requires rapid diagnostic identification and susceptibility testing to guide appropriate therapy.

Other names

Pathogenic bacteriaBacterial pathogensInfectious bacteria

Antibiotics target bacterial cell wall synthesis (e.g., beta-lactams), protein synthesis (e.g., macrolides), nucleic acid replication (e.g., fluoroquinolones), and metabolic pathways (e.g., sulfonamides) (NIH, PMC4378521).